106
Participants
Start Date
August 7, 2023
Primary Completion Date
March 14, 2025
Study Completion Date
March 14, 2025
NNC0491-6075
NNC0491-6075 will be administered as a subcutaneous injection in a skinfold in the abdomen or intravenously into a vein in the wrist, elbow, or the back of the hand.
Placebo
Placebo matched to NNC0491-6075 will be administered as a subcutaneous injection in a skinfold in the abdomen or intravenously into a vein in the wrist, elbow, or the back of the hand.
Altasciences Clinical LA, Inc., Cypress
Lead Sponsor
Novo Nordisk A/S
INDUSTRY